Acquisitions & Divestments

The list below offers extensive information about our past acquisitions and divestments.

Acquisitions

Name of Company
Transaction costs
Year Business Sector
Press Release
SpringWorks Therapeutics$ 3.4 bn2025HealthcareFurther Information
HUB Organoids Holding B.V.n/a2025Life ScienceFurther Information
Unity-SC€ 155 m2024ElectronicsFurther Information
Mirus Bio€ 550 m2024Life ScienceFurther Information
Mecaro Co. Ltd.€ 110 m2022ElectronicsFurther Information
MASTn/a2022Life ScienceFurther Information
Exelead$ 780 m2022Life ScienceFurther Information
Chord Therapeutics n/a2022HealthcareFurther Information
Amptecn/a2021Life ScienceFurther Information
Resolution Spectra Systemsn/a2020Life ScienceFurther Information
FloDesign Sonicsn/a2019Life ScienceFurther information
Intermolecular$ 62 m2019ElectronicsFurther information
Versum Materials€ 5.8 bn2019ElectronicsFurther information
Natrix Separationsn/a2017Life Sciencen/a
BioControl
n/a2017Life Science
n/a
Sigma-Aldrich
€ 13.1 bn
2015Life Science
Further Information
Ormet Circuits
n/a2015Electronicsn/a
Qlight Nanotech
n/a
2015Electronicsn/a
Peer+
n/a2014Electronicsn/a
AZ Electronics
€ 1.9 bn
2014Electronicsn/a
Biochrom AG
n/a
2012Life Science
n/a
CellASIC (USA)
n/a2012Life Science
n/a
Amnis (USA)
n/a
2011Life Science
n/a
heipha Dr. Müller GmbH/Hycon branch of Biotest AG
n/a
2011Life Science
n/a
Beijing Skywing Technology (China)
€ 14.5 m
2010Life Science
n/a
Millipore Corporation (US)
€ 5.1 bn
2010Life Science
n/a
Taizhu (China)
€ 26.3 m
2009Electronicsn/a
Bio-Fyt Pharma (Belgium)
€ 30.0 m
2008Healthcare
n/a
SeQuant
€ 6.9 m
2008Life Science
n/a
Serono (Switzerland)
€ 10.3 bn
2006Healthcare
n/a
Agribiotics Holdings (Canada)
€ 21.9 m
2006Electronicsn/a
Survac (Denmark)
€ 10.8 m
2005Healthcare
n/a
OLED and polymer electronics activities from Avecia (UK) incl. Covion (Germany)
€ 49.3 m
2005Electronicsn/a
NM Pharma (Scandinavia)
€ 49,1 m
2004
divested with EMD Generics
n/a
Nature's Best, VMS mail order (UK)
€ 22,8 m
2003Healthcare
n/a
Laboratoires Richelet (France)
€ 9.3 m
2002Healthcare
n/a

Divestments

Name of Company
Transaction value
Year Business
Press Release
Surface Solutions€ 665 m2024ElectronicsFurther Information
Allergopharman/a2020HealthcareFurther information
Consumer Health Business€ 3.4 bn2018HealthcareFurther information
Biosimilars Businessn/a2017Healthcaren/a
Pakistan Healthcare Business of Merck KGaA, Darmstadt, Germany
n/a2016Healthcaren/a
Discovery and Development Solutions
€ 22.6 m
2015Life Science
n/a
Mobile Energy Business (Germany)
n/a2012Electronicsn/a
Crop BioScience Business (USA, Canada & Argentina)
€ 208.2 m
2010EMD Serono
n/a
Théramex (Monaco & Italien)
€ 269.3 m
2010EMD Seronon/a
EMD Generics Division
€ 4.9 bn
2007n/an/a
ITO/CF Business (Taiwan)
€ 29 m
2006Electronicsn/a
Electronic Chemicals Business
€ 270 m
2005Electronicsn/a
Lab distribution VWR (US)
$ 1.68 bn
2004n/an/a
50% holding of Biomet-Merck KGaA, Darmstadt, Germany
$ 300 m
2004Electronicsn/a
453077651 453077651
Financials
Read More
Financials
Our Financial Reporting Center offers you the opportunity to select from financial data on an annual or quarterly basis.
investors-webcast investors-webcast
Webcasts & Presentations
learn more
Webcasts & Presentations
There is a large number of presentations and webcasts of different events available for download. They provide helpful insights into our company, our businesses and executives as well as our financial development.
478065661-Unrecognizable business people examining financial reports and analyzing business growth 478065661-Unrecognizable business people examining financial reports and analyzing business growth
Analysts & Consensus
Read More
Analysts & Consensus

Several banks and brokerages regularly cover Merck KGaA, Darmstadt, Germany by publishing analyses, short reviews and updates. An accurate and up to date consensus of these various projections is provided by VARA Research once per quarter.